Federico Brucoli

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

RSC advances

ChemMedChem

De Montfort University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

De Montfort University Oct 30 2017

United Kingdom

VC2020 Lecturer in Medicinal Chemistry :: School of Pharmacy

University of the West of Scotland Sep 19 2013 - Sep 14 2017

United Kingdom

Lecturer in Medicinal Chemistry :: School of Science and Sport

Publications

Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Nasrin Shokrzadeh Madieh, Sangeeta Tanna, Norah Ahmed Alqurayn, Alexandra Vaideanu, Andreas Schatzlein, Federico Brucoli
Aminobenzofuran-containing analogues of proximicins exhibit higher antiproliferative activity against human UG-87 glioblastoma cells compared to temozolomide. RSC advances 13 (12) (2023)
Nasrin Shokrzadeh Madieh, Sangeeta Tanna, Norah Ahmed Alqurayn, Alexandra Vaideanu, Andreas Schatzlein, Federico Brucoli
Aminobenzofuran-containing analogues of proximicins exhibit higher antiproliferative activity against human UG-87 glioblastoma cells compared to temozolomide. RSC advances 13 (12) (2023)
Lindsay Ferguson, Nasrin Shokrzadeh Madieh, Alexandra Vaideanu, Andreas Schatzlein, Joseph Festa, Harprit Singh, Geoffrey Wells, Sanjib Bhakta, Federico Brucoli
C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists. Chemical biology & drug design (2022)
Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, Piyali Mukherjee, Samsher Singh, Sujit Kamilya, Pushpendu Jalani, Swetarka Das, Arunava Dasgupta, Abhishake Mondal, Amit Kumar Das, Amit Singh, Federico Brucoli, Claire Bagnéris, Rachael Dickman, Vinay N Basavanakatti, Patibandla Naresh Babu, Vadivelan Sankaran, Abhimanyu Dev, Barij Nayan Sinha, Sanjib Bhakta, Venkatesan Jayaprakash
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition. Journal of medicinal chemistry 65 (1) (2022)
Federico Brucoli, Timothy D McHugh
Rifamycins: do not throw the baby out with the bathwater. Is rifampicin still an effective anti-tuberculosis drug? Future medicinal chemistry 13 (24) (2021)
Lindsay Ferguson, Sanjib Bhakta, Keith R Fox, Geoff Wells, Federico Brucoli
Synthesis and Biological Evaluation of a Novel C8-Pyrrolobenzodiazepine (PBD) Adenosine Conjugate. A Study on the Role of the PBD Ring in the Biological Activity of PBD-Conjugates. Molecules (Basel, Switzerland) 25 (5) (2020)
Mousumi Shyam, Deepak Shilkar, Harshita Verma, Abhimanyu Dev, Barij Nayan Sinha, Federico Brucoli, Sanjib Bhakta, Venkatesan Jayaprakash
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis. Journal of medicinal chemistry 64 (1) (2020)
Lindsay Ferguson, Geoff Wells, Sanjib Bhakta, James Johnson, Junitta Guzman, Tanya Parish, Robin A Prentice, Federico Brucoli
Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA. ChemMedChem 14 (19) (2019)
Angelo Iacobino, Federico Giannoni, Lanfranco Fattorini, Federico Brucoli
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions. The Journal of antibiotics 71 (9) (2018)

Federico Brucoli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Federico Brucoli